Alembic Pharmaceuticals rises on reporting 30% rise in Q4 consolidated net profit

27 Apr 2016 Evaluate

Alembic Pharmaceuticals is currently trading at Rs. 620.00, up by 5.10 points or 0.83% from its previous closing of Rs. 614.90 on the BSE.

The scrip opened at Rs. 613.00 and has touched a high and low of Rs. 643.00 and Rs. 593.00 respectively. So far 132531 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 791.70 on 15-Jul-2015 and a 52 week low of Rs. 443.00 on 28-Apr-2015.Last one week high and low of the scrip stood at Rs. 625.95 and Rs. 552.05 respectively. The current market cap of the company is Rs. 11853.88 crore.

The promoters holding in the company stood at 74.13% while Institutions and Non-Institutions held 12.92% and 12.96% respectively.

The company has posted a rise of 32.69% its net profit at Rs 89.02 crore for the quarter ended March 31, 2016 as compared to Rs 67.09 crore for the same quarter in the previous year. Total income of the company has increased by 19.65% at Rs 590.96 crore for quarter under review as compared to Rs 493.92 crore for the quarter ended March 31, 2015.

On consolidated basis, the company has posted a rise of 29.65% in its net profit after taxes and share of profit of associates at Rs 91.18 crore for the quarter ended March 31, 2016 as compared to Rs 70.33 crore for the corresponding quarter in the FY15. Total income of the company rose 24.63% at Rs 629.19 crore for quarter under review as compared to Rs 504.83 crore for the same quarter ended previous year.

For the year ended March 31, 2016, the company has posted over two fold jump in its net profit at Rs 698.13 crore as compared to Rs 286.61 crore for the same period in the previous year. Total income of company increased 48.41% at Rs 2997.25 crore for year under review as compared to Rs 2019.57 crore for the period ended March 31, 2015.

For the year ended March 31, 2016, on the consolidated basis, the company has posted over two fold jump in its net profit after taxes and share of profit of associates at Rs 719.44 crore as compared to Rs 282.93 crore for the same period in the previous year. Total income of company has increased by 53.24% at Rs 3154.22 crore for year under review as compared to Rs 2058.42 crore for the period ended March 31, 2015. 

Alembic Pharma Share Price

1055.00 4.85 (0.46%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.